VicPlas International Ltd. (SG:569)
SGX:569
Want to see SG:569 full AI Analyst Report?
569 Stock Chart & Stats
S$0.09
<S$0.01(2.13%)
At close: 4:00 PM EST
S$0.09
<S$0.01(2.13%)
Day’s Range― - ―
52-Week RangeS$0.07 - S$0.10
Previous CloseN/A
Volume100.00
Average Volume (3M)97.25K
Market Cap
S$43.44M
Enterprise ValueS$80.84M
Total Cash (Recent Filing)S$4.71M
Total Debt (Recent Filing)S$41.11M
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding511,537,700
10 Day Avg. Volume66,350
30 Day Avg. Volume97,253
Financial Highlights & Ratios
PEG Ratio-0.28
Price to Book (P/B)0.65
Price to Sales (P/S)0.39
P/FCF Ratio-7.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Business ModelOperating in both piping systems (construction, plumbing, infrastructure) and medical devices (catheters, healthcare components) gives VicPlas durable revenue diversification. This reduces single-market dependence, smooths demand cycles across industries, and supports resilience over the next several months.
Top-line Rebound In 2025A substantial revenue recovery in 2025 signals renewed demand and better utilization of fixed capacity. Sustained top-line growth improves operating leverage potential and provides a base for margin recovery if costs are managed, supporting medium-term profitability prospects.
Healthy Gross MarginsConsistently high gross margins imply product pricing power or efficient production for both piping and medical product lines. High gross margins create a buffer versus cost increases and support the potential to return to net profitability once operating expenses and cash conversion normalize.
Bears Say
Recent Shift To Net LossesThe transition from multi-year profitability to net losses weakens retained earnings and undermines the firm's ability to self-fund growth or cushion shocks. Persistent losses over several quarters risk long-term returns and could force strategic cost cuts or restructuring.
Weakened Operating Cash FlowMaterial deterioration in cash generation and repeated negative free cash flow constrain capital allocation, limit reinvestment and increase reliance on external financing. Over months this reduces flexibility to fund working capital, capex, or new product investments without raising debt or equity.
Rising LeverageAn increased debt burden amplifies fixed financial costs and reduces balance sheet flexibility. Higher leverage heightens refinancing and interest-rate risks and constrains strategic options, particularly while profitability and cash flow remain weak, making capital structure a medium-term risk.
VicPlas International Ltd. News
569 FAQ
What was VicPlas International Ltd.’s price range in the past 12 months?
VicPlas International Ltd. lowest share price was S$0.07 and its highest was S$0.10 in the past 12 months.
What is VicPlas International Ltd.’s market cap?
VicPlas International Ltd.’s market cap is S$43.44M.
When is VicPlas International Ltd.’s upcoming earnings report date?
VicPlas International Ltd.’s upcoming earnings report date is Sep 28, 2026 which is in 152 days.
How were VicPlas International Ltd.’s earnings last quarter?
VicPlas International Ltd. released its earnings results on Mar 13, 2026. The company reported -S$0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -S$0.007.
Is VicPlas International Ltd. overvalued?
According to Wall Street analysts VicPlas International Ltd.’s price is currently Overvalued.
Does VicPlas International Ltd. pay dividends?
VicPlas International Ltd. does not currently pay dividends.
What is VicPlas International Ltd.’s EPS estimate?
VicPlas International Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VicPlas International Ltd. have?
VicPlas International Ltd. has 511,537,700 shares outstanding.
What happened to VicPlas International Ltd.’s price movement after its last earnings report?
VicPlas International Ltd. reported an EPS of -S$0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.124%.
Which hedge fund is a major shareholder of VicPlas International Ltd.?
Currently, no hedge funds are holding shares in SG:569
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VicPlas International Ltd.
Vicplas International Ltd, an investment holding company, engages in the medical devices, and pipes and pipe fittings businesses in Singapore, Malaysia, the People's Republic of China, and the United Kingdom. The company manufactures, trades, and distributes piping systems for various industries, including waste and potable water systems for residential homes, schools, and commercial and industrial buildings; underground electrical and internal building wire piping systems; and data and signal line piping systems by telecommunications companies. It also designs, develops, manufactures, and assembles sterile and non-sterile medical devices; and provides project design and engineering services. Vicplas International Ltd was founded in 1993 and is headquartered in Singapore. Vicplas International Ltd is a subsidiary of Venner Capital S.A.
Technical Analysis
Asiamedic Limited
―
Medtecs International Corporation Ltd.
―
AJJ Medtech Holdings Limited
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―